Cuproptosis-Related Genes in Immune Infiltration and Diagnosis in Hepatitis B Virus-Related Acute Liver Failure

Jingwen Deng1, Tao Zhu2, Yueyang Wang3,4

  • 1Department of Medical Oncology Sir Run Run Shaw Hospital School of Medicine Zhejiang University Hangzhou China.

Insights

This study reveals that cuproptosis, a cell death process involving copper, is linked to immune changes in Hepatitis B virus-related acute liver failure (HBV-ALF). Seven core genes show diagnostic potential for HBV-ALF.

Area of Science:

  • Hepatology
  • Immunology
  • Cell Death Research

Background:

  • Hepatitis B virus (HBV) infection is a global health concern, with HBV-related acute liver failure (HBV-ALF) being a major cause of liver failure in China.
  • Cuproptosis, a novel form of programmed cell death regulated by copper, has emerged as a significant factor in cellular processes.

Purpose of the Study:

  • To investigate the role of cuproptosis in immune infiltration within HBV-related acute liver failure (HBV-ALF).
  • To identify potential diagnostic biomarkers and therapeutic targets for HBV-ALF based on cuproptosis-related genes.

Main Methods:

  • Utilized gene expression data from the Gene Expression Omnibus (GEO) database for HBV-ALF.
  • Performed enrichment analysis of differentially expressed genes (DEGs) and intersection analysis with cuproptosis-related genes (CRGs).
  • Conducted immune infiltration analysis, unsupervised clustering, and validation in clinical samples.

Main Results:

  • Enrichment analysis highlighted pathways related to copper ion response and acute inflammation in HBV-ALF.
  • Identified 7 core cuproptosis-related DEGs (CR-DEGs) with diagnostic value for HBV-ALF.
  • Revealed distinct immune infiltration patterns and potential crosstalk between ferroptosis and cuproptosis in HBV-ALF.

Conclusions:

  • The 7 identified CR-DEGs show significant diagnostic potential for HBV-ALF.
  • These CR-DEGs may serve as novel therapeutic targets for managing HBV-ALF.
  • Cuproptosis plays a crucial role in the immune landscape of HBV-ALF, offering new avenues for treatment.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...